GF Fund Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.7K Buy
1,207
+98
+9% +$1.55K ﹤0.01% 502
2026
Q2
$15K Buy
1,109
+16
+1% +$238 ﹤0.01% 505
2026
Q1
$16.8K Buy
1,093
+129
+13% +$2.15K ﹤0.01% 517
2025
Q4
$17.4K Sell
964
-52
-5% -$895 ﹤0.01% 523
2025
Q3
$16.4K Buy
1,016
+199
+24% +$2.91K ﹤0.01% 513
2025
Q2
$8.9K Hold
817
– – ﹤0.01% 581
2025
Q1
$10.2K Buy
817
+146
+22% +$2.4K ﹤0.01% 561
2024
Q4
$13.3K Buy
+671
New +$7.43K ﹤0.01% 512

Other funds holding MESO

GF Fund Management's MESO Position: Q3 2026 in Review

GF Fund Management increased its Mesoblast (MESO) stake by 8.8% in Q3 2026, buying an estimated $1.55K and bringing the position to 1,207 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

GF Fund Management first reported a position in MESO in Q4 2024 and has held it in 8 quarters since. 14 funds tracked by Wall St. Rank hold MESO as of Q3 2026.

  • GF Fund Management held 1,207 shares of Mesoblast worth $17.7K as of Q3 2026.
  • GF Fund Management bought 98 Mesoblast shares in Q3 2026, an estimated $1.55K.
  • Mesoblast made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #502 holding.
  • GF Fund Management first reported a position in Mesoblast in Q4 2024 and has held it in 8 quarters since.
  • 14 funds tracked by Wall St. Rank held Mesoblast as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.